Dr. Anindya Mukherjee

Senior Consultant - (Medical Oncology)

Oncology

Qualification:

MBBS, MD, DrNB

Experience:12+ Years

Rating:Patient Satisfaction Rate: 5 | Rating: 5/5 ⭐

Languages:English, Hindi

Book an Appointment

Home Find a DoctorDr. Anindya Mukherjee

About

Dr. Anindya Mukherjee is a highly competent and research-driven Medical Oncologist with strong academic and clinical training from leading cancer institutes. He possesses extensive experience in the management of solid tumors and hematologic malignancies, integrating modern therapeutic approaches such as chemotherapy, immunotherapy, and targeted therapy. Dr. Mukherjee’s clinical practice emphasizes precision oncology, personalized treatment planning, and evidence-based decision-making to achieve optimal outcomes. His compassionate patient-centric care and active participation in oncology research reflect his commitment to advancing cancer treatment in India.

Experience

Attending Consultant, Rajiv Gandhi Cancer Institute and Research Centre
Consultant Radiation Oncology - Meherbai Tata Memorial Hospital

Specialization & Expertise

Solid and hematologic malignancies
Chemotherapy, immunotherapy & targeted therapy
Breast, lung & gastrointestinal cancers
Precision & molecular oncology
Lymphoma and leukemia management
Multidisciplinary and palliative cancer care

Qualifications

DrNB - Medical Oncology
MD - Radiotherapy
MBBS

Memberships

ISMPO Symposium – Manthan Chapter 1: Advancing Lung Cancer Treatment Landscape, January 2023
Commendable Thesis Award, DrNB (Medical Oncology), 2023
Active participant and presenter at ASCO 2024 and ISMPO 2022–2023 conferences

Our Medical Experts

Dr. Anil Thakwani

Senior Consultant & H.O.D - (Radiation Oncology)

Oncology

Experience: 25+ Years

Radiation Oncology
Gynecologic Oncology
Pediatric Oncology
Radiation Therapy by Truebeam STX SRT, SBRT, Heart Sparing Radiation By Gating
HDR Brachytherapy
Medical Management of Cancer by Chemotherapy, Target Therapy, Hormone Therapy, Immunotherapy
Cancers of Ovary, Peritoneal Cancers
HIPEC & PIPEC
Cancers of Ovary, Peritoneal Cancers by Intraperitoneal Chemotherapy

View Profile Book appointment

Dr. Hemkant Verma

Consultant - (Surgical Oncology)

Oncology

Experience: 12+ Years

Breast Oncoplasty
Thoracic Oncology
Gynaecological Malignancies
Head & Neck Cancers
Gastrointestinal and HPB Malignancy
Laparoscopic Cancer Surgeries
Organ Preservation Cancer Surgeries
Cancer Awareness and Screening Programs

View Profile Book appointment

Dr. Gulafshan Jabi

Senior Resident - (Radiation Oncologist)

Oncology

Experience: 8+ Years

Dr. Gulafshan Jabi specializes in:

Radiation Oncology

Treatment of various cancers using external beam radiotherapy and brachytherapy
Expertise in 2D and 3D treatment planning using advanced systems (TPS)
Hands-on experience with Elekta, Varian, and Cobalt therapy machines

Brachytherapy

High Dose Rate (HDR) brachytherapy using Iridium source
Intracavitary and interstitial applications for gynecologic and other cancers

Teletherapy

Extensive experience in treating patients using Cobalt units and LINAC systems
Skilled in planning and delivering radiation therapy across multiple cancer types

Oncology Patient Care

Holistic patient management including counseling, chemotherapy OPD involvement, and follow-up care
Team-based multidisciplinary approach in cancer care

View Profile Book appointment

Dr. Pawan Kumar Singh

Vice Chairman - (Haemato-Oncology & BMT)

Oncology

Experience: 15+ Years

Leukemia, lymphoma, and multiple myeloma
High-dose and induction chemotherapy (AML, ALL, MPAL)
Targeted and immunotherapies in hematologic malignancies
Allogeneic bone marrow transplantation (MSD, MUD, Haplo)
Aplastic anemia and bone marrow failure syndromes
High-risk and complex transplant cases
Bone marrow transplantation in special clinical scenarios (Jehovah’s Witness patients, HIV, viral infections, CKD on dialysis)
Thalassemia and sickle cell disease
Autologous BMT for autoimmune diseases, especially multiple sclerosis
Graft manipulation and T-cell–depleted haploidentical BMT
CAR-T cell therapy